T

he drug industry’s war chest is going a long way.

The two big trade groups for drug makers, the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization, spent more lobbying the federal government in the first six months of this year than they have in that period since at least 1999, according to lobbying disclosure filings updated this week.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine